Organ systems

Coborn's Helps Make Diabetes Management Easy and Affordable with New $9.99 Diabetes Management Program

Monday, November 18, 2019 - 10:19pm

MINNEAPOLIS, Nov. 18, 2019 /PRNewswire/ --Minnesota Grocery/Pharmacy chain Coborn's launches their new $9.99 Diabetes Management Program to help customers better afford and manage diabetes.

Key Points: 
  • MINNEAPOLIS, Nov. 18, 2019 /PRNewswire/ --Minnesota Grocery/Pharmacy chain Coborn's launches their new $9.99 Diabetes Management Program to help customers better afford and manage diabetes.
  • Even with insurance, many with diabetes find themselves paying thirty, or even more, dollars a month for their diabetes test strips.
  • "ARKRAY's goal is to help make diabetes management easy and affordable.
  • As Your Diabetes Health Ally, ARKRAY helps provide cost-effective diabetes care for those with the disease and their healthcare providers.

The Dry Eye Disease market studied was valued at USD 4,539.22 million in 2018, and is expected to reach USD 6,175.96 million by 2024, with an anticipated CAGR of 5.23%, during the forecast period (2019

Monday, November 18, 2019 - 9:10pm

The Dry Eye Disease market studied was valued at USD 4,539.22 million in 2018, and is expected to reach USD 6,175.96 million by 2024, with an anticipated CAGR of 5.23%, during the forecast period (2019-2024).

Key Points: 
  • The Dry Eye Disease market studied was valued at USD 4,539.22 million in 2018, and is expected to reach USD 6,175.96 million by 2024, with an anticipated CAGR of 5.23%, during the forecast period (2019-2024).
  • Additionally, working for long hours on computer screens as well as long term contact lens use cause dry eye.
  • There are several ocular manifestations for which several dry eye products are used for the treatment of the disease.
  • These drugs are highly useful in short term efficacy and thus prescribed mostly for acute cases of dry eye diseases.

The global digital diabetes management market is growing at a CAGR of over 18% during the forecast period 2018-2024

Monday, November 18, 2019 - 9:05pm

The global digital diabetes management market is growing at a CAGR of over 18% during the forecast period 20182024.

Key Points: 
  • The global digital diabetes management market is growing at a CAGR of over 18% during the forecast period 20182024.
  • The global digital diabetes management market has witnessed significant growth in sales volume due to the growing prevalence of diabetes and the increasing awareness of self-management of the disease.
  • Hence, the introduction of advanced digital devices has enabled both patients and healthcare professionals to monitor blood glucose levels in real-time, thereby enhancing the management of diabetes.
  • The following factors are likely to contribute to the growth of the market during the forecast period:
    The study considers the present scenario of the digital diabetes management market and its market dynamics for the period 2018?2024.

NeoRhythm: Breakthrough in Brain Science

Monday, November 18, 2019 - 4:04pm

NEW YORK, Nov. 18, 2019 /PRNewswire/ -- MDCN Technologies just launched NeoRhythm - a breakthrough wearable in brain science that can help people sleep better, de-stress and improve focus with this next-generation neurostimulation headband.

Key Points: 
  • NEW YORK, Nov. 18, 2019 /PRNewswire/ -- MDCN Technologies just launched NeoRhythm - a breakthrough wearable in brain science that can help people sleep better, de-stress and improve focus with this next-generation neurostimulation headband.
  • Our brain has a wonderful ability to adjust its own brainwaves to external frequencies the process of doing this intentionally is called brainwave entrainment.
  • By using brainwave entrainment to stimulate the brain to work at specific frequencies, NeoRhythm helps you get into the desired state of mind quicker and easier.
  • The brain adapts to these frequencies, reaching the desired state of mind quicker and easier.

Asia-Pacific Respiratory Syncytial Virus Market: Epidemiology Forecast to 2028 - ResearchAndMarkets.com

Monday, November 18, 2019 - 6:31pm

The "Respiratory Syncytial Virus: Epidemiology Forecast in Asia-Pacific Markets to 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Respiratory Syncytial Virus: Epidemiology Forecast in Asia-Pacific Markets to 2028" report has been added to ResearchAndMarkets.com's offering.
  • Respiratory syncytial virus (RSV) is a common respiratory infection that most children will be infected with by the time they are two years old.
  • The Respiratory Syncytial Virus (RSV) Epidemiology Report and Model provide an overview of the risk factors and global trends RSV in the five growth markets (5GM: Japan, Australia, urban China, India, and South Korea).
  • The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 5GM.

Mesa, Ariz. Becomes First-Ever Autism Certified City in U.S.

Monday, November 18, 2019 - 4:00pm

View the full release here: https://www.businesswire.com/news/home/20191118005046/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20191118005046/en/
    Mesa, Ariz. is the first-ever Autism Certified City in the U.S. Nearly 4,000 community members have completed or committed to autism certification.
  • In total, almost 60 businesses and organizations in Mesa and the surrounding area completed autism certification training, and are now each deemed a Certified Autism Center by IBCCES.
  • In April 2019, IBCCES named Visit Mesa the countrys first-ever destination marketing organization designated as a Certified Autism Center.
  • Visitors can download the Autism Travel Guide , a helpful travel planning resource featuring all Mesa-area Certified Autism Centers and participate in the Visit Mesa Autism Travel GeoTour.

Intestinal Health Specialist Mardell Hill Provides Simple Tips for Complete Abdominal Comfort

Monday, November 18, 2019 - 1:33pm

Author and certified colon specialist Mardell Hill offers the tools for maintaining a healthy digestive system to help improve comfort in her book Intestinal Health ~ A Practical Guide to Complete Abdominal Health published by Rowman & Littlefield.

Key Points: 
  • Author and certified colon specialist Mardell Hill offers the tools for maintaining a healthy digestive system to help improve comfort in her book Intestinal Health ~ A Practical Guide to Complete Abdominal Health published by Rowman & Littlefield.
  • "In my book, Intestinal Health ~ A Practical Guide to Complete Abdominal Comfort, I respond to commonly asked questions and offer safe, effective, and natural solutions for digestive health and self-care to prevent or resolve issues.
  • Intestinal Health ~ A Practical Guide to Complete Abdominal Comforteducates those of all ages about the digestive system and provides simple, self-care techniques using natural solutions to break through digestive disorders and achieve everyday relief from many causes of abdominal discomfort.
  • For Review copies of Intestinal Health ~ A Practical Guide to Complete Abdominal Health please contactGarrett Bond Associate Publicist Rowman & Littlefield 4501 Forbes Blvd, Lanham, MD 20706 Phone: 301-459-3366 ext.

Nisonic Demonstrates Automatic Measurements of Optic Nerve Sheath Diameter as a Marker for Increased Intracranial Pressure Using Transorbital Ultrasound at Medica In Düsseldorf, Germany

Monday, November 18, 2019 - 1:05pm

Nisonic is developing a novel method using properties of the optic nerve sheath to determine the patient's ICP.

Key Points: 
  • Nisonic is developing a novel method using properties of the optic nerve sheath to determine the patient's ICP.
  • Nisonic's method is based on using information about the optic nerve sheath obtained by placing ultrasound transducer on the eyelid.
  • When brain pressure increases, the optic nerve sheath widens and becomes stiffer, and Nisonic combines the optic nerve sheath diameter (ONSD) with additional information gathered from the nerve sheath to estimate the pressure.
  • To enable easy and fast measurements, Nisonic is using Machine Learning methods and has designed a probe optimized for transorbital ultrasound", says Tormod Selbekk (CTO).

Nisonic Demonstrates Automatic Measurements of Optic Nerve Sheath Diameter as a Marker for Increased Intracranial Pressure Using Transorbital Ultrasound at Medica In Düsseldorf, Germany

Monday, November 18, 2019 - 12:59pm

Nisonic is developing a novel method using properties of the optic nerve sheath to determine the patient's ICP.

Key Points: 
  • Nisonic is developing a novel method using properties of the optic nerve sheath to determine the patient's ICP.
  • Nisonic's method is based on using information about the optic nerve sheath obtained by placing ultrasound transducer on the eyelid.
  • When brain pressure increases, the optic nerve sheath widens and becomes stiffer, and Nisonic combines the optic nerve sheath diameter (ONSD) with additional information gathered from the nerve sheath to estimate the pressure.
  • To enable easy and fast measurements, Nisonic is using Machine Learning methods and has designed a probe optimized for transorbital ultrasound", says Tormod Selbekk (CTO).

Amarantus Provides Recapitalization Update to Shareholders

Monday, November 18, 2019 - 1:30pm

This plan would also allow for the settlement of the Companys outstanding liabilities and potentially provide significant upside for Amarantus shareholders.

Key Points: 
  • This plan would also allow for the settlement of the Companys outstanding liabilities and potentially provide significant upside for Amarantus shareholders.
  • Amarantus also continues to hold a 31.5% common equity position in Avant Diagnostics , which was taken private in first half of 2019.
  • At that time, Amarantus will receive additional common shares of Todos to bring Amarantus ownership in Todos to 49% prior the expected uplist capital raise.
  • We believe there is tremendous value in the Amarantus portfolio:
    Phase 2b - Parkinsons levodopa-induced dyskinesia: Next Step: Reformulation -
    Phase 2 Agitation in Alzheimers.